ADC Therapeutics’ $175 Million Senior Secured Term Loan and Existing Senior Secured Convertible Notes from Owl Rock and Oaktree

Homburger and Davis Polk & Wardwell advised ADC Therapeutics on the deal.DC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced that it has…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now